Number of participants (%) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All countries (N = 1675) | Czech Republic (n = 356) | Germany (n = 335) | United Kingdom (n = 323) | Italy (n = 338) | Sweden (n = 323) | p-value* | |||||||
Age group (years) | .090 | ||||||||||||
40–49 | 495 | (29.6%) | 100 | (28.1%) | 96 | (28.7%) | 101 | (31.3%) | 102 | (30.2%) | 96 | (29.7%) | |
50–59 | 490 | (29.3%) | 90 | (25.3%) | 109 | (32.5%) | 101 | (31.3%) | 96 | (28.4%) | 94 | (29.1%) | |
60–69 | 494 | (29.5%) | 131 | (36.8%) | 82 | (24.5%) | 82 | (25.4%) | 101 | (29.9%) | 98 | (30.3%) | |
70–75 | 196 | (11.7%) | 35 | (9.8%) | 48 | (14.3%) | 39 | (12.1%) | 39 | (11.5%) | 35 | (10.8%) | |
Education (ISCED) | <.001 | ||||||||||||
High | 393 | (23.5%) | 52 | (14.6%) | 65 | (19.4%) | 116 | (35.9%) | 43 | (12.7%) | 117 | (36.2%) | |
Medium | 817 | (48.8%) | 256 | (71.9%) | 207 | (61.8%) | 111 | (34.4%) | 112 | (33.1%) | 131 | (40.6%) | |
Low | 465 | (27.8%) | 48 | (13.5%) | 63 | (18.8%) | 96 | (29.7%) | 183 | (54.1%) | 75 | (23.2%) | |
Personal history of female cancer | .829 | ||||||||||||
Yes | 104 | (6.2%) | 20 | (5.6%) | 23 | (6.9%) | 19 | (5.9%) | 20 | (5.9%) | 22 | (6.8%) | |
Unknown | 25 | (1.5%) | 6 | (1.7%) | 1 | (0.3%) | 4 | (1.2%) | 7 | (2.1%) | 7 | (2.2%) | |
No | 1546 | (92.3%) | 330 | (92.7%) | 311 | (92.8%) | 300 | (92.9%) | 311 | (92.0%) | 294 | (91.0%) |